Abacavir

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Abacavir and local guidelines before prescribing.

Nucleoside analogue antiviral

Mechanism

Nucleoside reverse transcriptase inhibitor.

Uses

HIV infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypersensitivity reaction (HLA-B*5701), nausea, cardiovascular risk, fever.

Interactions

Alcohol raises levels.

Contraindications and cautions

HLA-B*5701 positive, severe liver impairment

Monitoring

HLA-B*5701, LFT

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

Avoid in moderate to severe hepatic impairment

Overdose and reversal

Supportive

Special advice

HLA-B*5701 test before starting; never rechallenge after hypersensitivity.

More from the textbook: uses, cautions and other points
Where it is discussed in the book